UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014548
Receipt number R000016774
Scientific Title Clinical Reserch of Angiographic CT with Intravenous Contrast Injection
Date of disclosure of the study information 2014/07/14
Last modified on 2016/07/17 14:22:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Reserch of Angiographic CT with Intravenous Contrast Injection

Acronym

Clinical Reserchi of ivACT

Scientific Title

Clinical Reserch of Angiographic CT with Intravenous Contrast Injection

Scientific Title:Acronym

Clinical Reserchi of ivACT

Region

Japan


Condition

Condition

Untreated unruptured cerebral aneurysms, untreated stenosis of intracranial arteries, clipped cerebral aneurysms, coiled cerebral aneurysms, stented intracranial arteries

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of angiographic CT with intravenous contrast injection (ivACT) compared with CT angiography (CTA) or MR angiography (MRA).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Various measured values and image quality

Key secondary outcomes

Radiocontrast-induced deterioration in renal function
Allergic reaction to contrast agent
Other adverse event


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

angiographic CT with intravenous contrast injection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients scheduled for CT angiography of untreated unruptured cerebral aneurysm
2) Patients scheduled for CT angiography of untreated intracranial arterial stenosis
3) Patients scheduled for CT angiography of clipped cerebral aneurysm
4) Patients scheduled for MR angiography of coiled cerebral aneurysm
5) Patients scheduled for CT angiography of stented intracranial arterial stenosis

Key exclusion criteria

1) Patient of chronic kidney disease (estimated glomerular filtration rate < 60ml/min/1.73m2)
2) Patient with a history of allergic reaction to contrast agent
3) Pregnant patient or patient who may become pregnant
4) Lactating woman
5) Patient who cannot understand the explanation of study or express one's consent due to impaired consciousness or dementia
6) Patient who is judged as inadequate for the study by responsible person or other members of study

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomohito Hishikawa

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Departement of Neurological Surgery

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama

TEL

086-235-7336

Email

t-hishi@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masafumi Hiramatsu

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Departement of Neurological Surgery

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama

TEL

086-235-7336

Homepage URL


Email

tzigane_ravel@yahoo.co.jp


Sponsor or person

Institute

Departement of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Institute

Department

Personal name



Funding Source

Organization

The Japanese Society for Neuroendovascular Therapy

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山大学病院(岡山県)


Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 05 Month 20 Day

Date of IRB


Anticipated trial start date

2014 Year 07 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 07 Month 14 Day

Last modified on

2016 Year 07 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016774


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name